Back
Amphastar Pharmaceuticals Vs. BridgeBio Pharma Industry Stock Comparison
Buy
51
AMPH
Amphastar Pharmaceuticals
Last Price:
45.50
Seasonality Move:
6.73%
Buy
55
BBIO
BridgeBio Pharma
Last Price:
24.84
Seasonality Move:
13.43%
Buy
51
Amphastar Pharmaceuticals (AMPH)
is a Buy
Is Amphastar Pharmaceuticals a Buy, Sell or Hold?
- The current Amphastar Pharmaceuticals [AMPH] share price is $47.71. The Score for AMPH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- AMPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy, Sell or Hold?
- The current BridgeBio Pharma [BBIO] share price is $24.62. The Score for BBIO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals's stock price today?
-
The Amphastar Pharmaceuticals share price today is $47.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPH is experiencing selling pressure, which indicates risk of future bearish movement.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $24.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 44.63 | Sell |
| Chaikin Money Flow: | -261939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.64 - 51.44) | Sell |
| Bollinger Bands (100): | (40.99 - 49.49) | Buy |
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 46.02 | Sell |
| Chaikin Money Flow: | -1350432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.15 - 25.99) | Sell |
| Bollinger Bands (100): | (24.18 - 27.42) | Sell |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.62 | Sell |
| 20-day SMA: | 50.14 | Sell |
| 50-day SMA: | 48.39 | Sell |
| 200-day SMA: | 45.08 | Buy |
| 8-day EMA: | 49.1 | Sell |
| 20-day EMA: | 49.43 | Sell |
| 50-day EMA: | 48.3 | Sell |
| 200-day EMA: | 46.28 | Buy |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.69 | Sell |
| 20-day SMA: | 25.1 | Sell |
| 50-day SMA: | 25.95 | Sell |
| 200-day SMA: | 27.74 | Sell |
| 8-day EMA: | 25.48 | Sell |
| 20-day EMA: | 25.28 | Sell |
| 50-day EMA: | 25.51 | Sell |
| 200-day EMA: | 26.74 | Sell |
Amphastar Pharmaceuticals Earnings Growth & AMPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.40 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.66 per share.
Amphastar Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BridgeBio Pharma Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||